Navigation Links
Brigham and Women's Researchers Partner with Vocantas to use CallAssure in Clinical Research Study
Date:11/19/2008

OTTAWA, Nov. 19 /PRNewswire/ - Vocantas Inc., developer of voice solutions for healthcare, has been selected by Boston's Brigham and Women's Hospital (BWH) to help researchers assess the impact of automated telephone follow-up systems on the management of patients on commonly prescribed medications. Using interactive voice response (IVR) and speech technology, the CallAssure system enables healthcare providers to evaluate real time patient data. Study researchers believe that this proactive outreach may facilitate communication between patients and their physicians between visits to address potentially serious issues.

Leading the project is researcher Jennifer Haas, MD, MSPH, at BWH's Division of General Medicine. Dr. Haas has made major contributions in areas focused on the use of technology to improve the quality and safety of patient care, as well as access to care, particularly among the poor and uninsured.

"After three weeks of pilot test calls, the system is functioning well," says Haas. "We are looking forward to implementing the technology in our trial to quickly and effectively reach participants and to manage the data efficiently."

Supporting HL7 standards, the CallAssure system automatically records any symptoms the patient is experiencing in a note which is then attached to the patient's electronic medical record.

Primary care patients at BWH who are prescribed any of 32 target medications for a range of chronic conditions, from allergies to high cholesterol, are enrolled in the study. Candidates receive a letter explaining how the study works, and may choose to opt out. More than 90% of patients have chosen to try the program at the time of this release.

Aarthi Iyer, MPH with the Division of General Medicine at BWH, explains that there are a number of potential problems that exist with identifying side effects from prescribed medications.

"Typically, medication follow-up is done during the next appointment. This can mean that a lot of time passes without symptoms and side effects being reported." says Iyer. "The automated patient poll serves as check-up between doctor visits."

Another key feature of CallAssure is that the survey is dynamic. Based on the medication and the patient's responses to questions, the survey script will trigger an email notification immediately to a physician for follow-up.

"Previously, information about symptoms and side effects was not collected in a standard and thorough manner," says Iyer. "Now, we are able to test a method that closes that follow-up loop and provides real-time reporting for review and analysis.

"We look forward to exploring potential ways to improve patient safety with new technology, and are happy to be working with the Vocantas team on this project."

About Vocantas

Vocantas is a developer of interactive voice response systems (IVRS) that use advanced computer telephony and speech technology to provide its customers with cost-effective customer outreach solutions. The company's easy-to-use, turn-key solutions offer customizable core features and optional enhancements that integrate seamlessly with existing systems. Its products have particular application in the healthcare, utilities and customer service environments where they have been proven to increase efficiencies while minimizing operational costs. For more information, please visit www.vocantas.com

"CallAssure" is a trademark of Vocantas Inc. The names of other companies

or products mentioned herein may be the trademarks of their respective

owners.


'/>"/>
SOURCE VOCANTAS
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Lilly and Partners In Health, Brigham and Womens Hospital Team Up to Fight MDR-TB in Former Soviet Republics
2. Womenshealthchannel Enhancements Support Pregnant Teens
3. Leeds researchers reshape the future of drug discovery
4. UNC researchers find clue to stopping breast-cancer metastasis
5. U of U researchers to use patients own stem cells to treat heart failure
6. Researchers identify toehold for HIVs assault on brain
7. Researchers Tackle CLL, Diabetes and Trauma-Hemorrhage
8. Researchers Use New Method to Control Bleeding in Hemophilia
9. Stem cells with potential to regenerate injured liver tissue identified by Penn researchers
10. Protein can nurture or devastate brain cells, depending on its friends, researchers find
11. Researchers find stem cells from monkey teeth can stimulate growth and generation of brain cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... St. Louis, Missouri (PRWEB) , ... February 10, ... ... 11-14, 2016, in San Diego, will bring together more than 200 of the ... in healthcare for the future. , “The true benefit of the Forum is ...
(Date:2/10/2016)... ... 10, 2016 , ... AHRA: The Association for Medical Imaging ... Fox will serve as keynote speaker at the organization’s 2016 Spring Conference. Fox’s ... more effectively communicate with their own organizational staff and leadership. , “I ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined the award-winning ... to physicians. The integration will enable Allscripts users to post open appointments to ... mobile app. , The partnership gives Everseat substantial added power to help Allscripts ...
(Date:2/10/2016)... ... February 10, 2016 , ... The recreational use of marijuana has been ... still face a lot of restrictions as to where they can smoke pot. ... use” and that cannabis “may not be consumed openly or publicly.” , Given the ...
(Date:2/10/2016)... ... February 09, 2016 , ... According to a recent article published ... number of patients under the age of 30. According to Southern California based medical ... and may indicate an overall shift in the rapidly growing social acceptance of cosmetic ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , February 10, 2016 ... new market research report "Pharmaceutical Packaging Equipment Market by ... Labeling & Serialization), by Product Type (Tablet, Powder, Cream, ... published by MarketsandMarkets, studies the global market during the forecast ... to grow at a CAGR of 6.9% during the ...
(Date:2/10/2016)... On Tuesday, February 9th, the U.S. ... its Arthritis Advisory Committee to discuss Celltrion,s ... Johnson,s Remicade and most likely the second ... The Biologics Prescribers Collaborative (BPC) along with ... Patient Access, American Association of Clinical Endocrinologists, ...
(Date:2/10/2016)... 10, 2016 --> ... Therapeutics and Companion Diagnostic Market to 2019 - ... Environment" research report indicates that the core personalized ... by 2020 growing at a CAGR of 8.74%. ... and targeted therapeutics and is dominated by oncology, ...
Breaking Medicine Technology: